Quintiles Transnational IPO Research Information

Quintiles Transnational IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Quintiles Transnational, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Quintiles Transnational	Q -	$36.00-$40.00	$40.00	$43.76	23.7 million	5/9/2013
Underwriter(s): Morgan Stanley, Barclays, J.P. Morgan
Co-Manager(s): Citigroup, Goldman Sachs & Co., Wells Fargo Securities, BofA Merrill Lynch, Deutsche Bank Securities, Baird, William Blair, Jefferies, Guggenheim Securities, Piper Jaffray, Raymond James, RBC Capital Markets, UBS Investment Bank
Industry: Health Care
Filing(s):

Quintiles Transnational Quote & Chart - Click for current quote - Q

About Quintiles Transnational (adapted from Quintiles Transnational prospectus):
They are the largest provider of clinical trial services to pharmaceutical companies.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "Q" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.